Curaleaf wins Spanish medicines agency registration for standardized cannabis preparations

  • Curaleaf secured AEMPS registration in Spain for two standardized cannabis preparations, clearing supply to hospital pharmacies under Royal Decree 903/2025.
  • The products are THC-dominant and CBD-dominant, registered as CAN-1 and CAN-2 under Spain’s new medicinal cannabis framework.
  • Registrations position Curaleaf as the first to register standardized cannabis preparations in Spain, supporting future patient access via magistral formulas.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE02337) on July 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.